Portfolio company
Phagos
France · £21.3m raised
Raised
£21.3m
Latest stage
Series A
Rounds recorded
1
Backed by
9 investors
Sectors
About
The company develops AI-powered bacteriophage treatments to combat antibiotic-resistant bacterial diseases, primarily for the animal farming and healthcare sectors.
SourceFunding history · 1
Similar companies
PhageLab
PhageLab develops bacteriophage treatments to control bacterial pathogens in livestock and poultry production, reducing the industry's reliance on antibiotics.
EcoPhage
This company develops bacteriophage-based biopesticides to manage bacterial diseases in crops for the agricultural industry.
Phaxiam
The company develops bacteriophage-based treatments to combat antibiotic-resistant bacterial infections for patients with severe hospital-acquired or chronic respiratory conditions.
Aviwell
This company develops microbiota-based feed solutions using an AI discovery platform to improve livestock growth and health for the agri-food industry.
Resilient Biotics
This company develops microbiome-derived live biotherapeutics to prevent and treat respiratory diseases in livestock and humans.
MEDEA
This company develops bacteriophage-based antimicrobial products for customers in the human health, animal welfare, aquaculture and food protection sectors.
Baseimmune
The company develops AI-designed vaccines and antigens for pharmaceutical partners and biotech researchers to treat infectious diseases and chronic conditions in humans and animals.
Locus Biosciences
This biotechnology company develops engineered bacteriophage therapies for patients with drug-resistant bacterial infections using CRISPR technology and artificial intelligence.
